These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 17491330)

  • 21. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
    Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
    Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes.
    Yuki N
    Lancet Infect Dis; 2001 Aug; 1(1):29-37. PubMed ID: 11871407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathogenesis of Guillain-Barré syndrome and Fisher's syndrome: molecular mimicry between antecedent infectious agents and components of nerve tissues].
    Yuki N
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1373-5. PubMed ID: 8752400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology.
    Yuki N; Kuwabara S
    J Peripher Nerv Syst; 2007 Dec; 12(4):238-49. PubMed ID: 18042134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of Guillain-Barré syndrome after Campylobacter jejuni enterocolitis: anti-ganglioside antibody levels with or without Guillain-Barré syndrome].
    Watanabe H; Shindo K; Nakamura Y; Nagamatsu M; Shiozawa Z; Kusunoki S
    Rinsho Shinkeigaku; 2001 Sep; 41(9):625-7. PubMed ID: 11968750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic malignant syndrome and acute motor axonal neuropathy after Campylobacter jejuni infection.
    Rajabally YA; Ramlackhansingh A; Fraser M; Abbott RJ
    Neurophysiol Clin; 2009 Aug; 39(3):135-8. PubMed ID: 19716463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier.
    Moran AP; Annuk H; Prendergast MM
    J Neuroimmunol; 2005 Aug; 165(1-2):179-85. PubMed ID: 15993494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Guillain-Barré syndrome and infection].
    Saida T; Hao Q; Obayashi H; Nishimura K; Ozawa K; Saida K
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1378-9. PubMed ID: 8752403
    [No Abstract]   [Full Text] [Related]  

  • 30. The sialic acid residue is a crucial component of C. jejuni lipooligosaccharide ganglioside mimicry in the induction Guillain-Barré syndrome.
    Xiang SL; Zhong M; Cai FC; Deng B; Zhang XP
    J Neuroimmunol; 2006 May; 174(1-2):126-32. PubMed ID: 16567003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barré syndrome.
    Yuki N
    Cell Mol Life Sci; 2000 Apr; 57(4):527-33. PubMed ID: 11130452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-ganglioside antibody and neuropathy: review of our research.
    Yuki N
    J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Campylobacter jejuni lipopolysaccharides from Guillain-Barré syndrome patients induce IgG anti-GM1 antibodies in rabbits.
    Ang CW; Endtz HP; Jacobs BC; Laman JD; de Klerk MA; van der Meché FG; van Doorn PA
    J Neuroimmunol; 2000 May; 104(2):133-8. PubMed ID: 10713352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry.
    Koga M; Gilbert M; Li J; Koike S; Takahashi M; Furukawa K; Hirata K; Yuki N
    Neurology; 2005 May; 64(9):1605-11. PubMed ID: 15883324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome.
    Jacobs BC; Koga M; van Rijs W; Geleijns K; van Doorn PA; Willison HJ; Yuki N
    J Neuroimmunol; 2008 Feb; 194(1-2):181-90. PubMed ID: 18178257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complex of GM1- and GD1a-like lipo-oligosaccharide mimics GM1b, inducing anti-GM1b antibodies.
    Koga M; Gilbert M; Li J; Yuki N
    PLoS One; 2015; 10(4):e0124004. PubMed ID: 25867522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymmetric Guillain-Barré syndrome.
    Logullo F; Manicone M; Di Bella P; Provinciali L
    Neurol Sci; 2006 Nov; 27(5):355-9. PubMed ID: 17122947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni enteritis].
    Tsuda N; Negoro K; Morimatsu M; Saito K; Yuki N
    Rinsho Shinkeigaku; 1995 Feb; 35(2):208-10. PubMed ID: 7781242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fulminant Guillain-Barrè syndrome after Campylobacter jejuni enteritis and anti-ganglioside antibody.
    Saito T
    Intern Med; 2002 Oct; 41(10):760-1. PubMed ID: 12412991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.